- Research article
- Open Access
- Open Peer Review
Edible Bird’s Nest attenuates high fat diet-induced oxidative stress and inflammation via regulation of hepatic antioxidant and inflammatory genes
BMC Complementary and Alternative Medicinevolume 15, Article number: 310 (2015)
Edible Bird’s nest (EBN) is an antioxidant-rich supplement that is popular in many parts of Asia. Its antioxidant and anti-inflammatory properties have been reported using in vitro system. This paper aimed to determine the antioxidant and anti-inflammatory effects of EBN in in high fat diet induced rats model.
We evaluate if those properties can be translated in rats. High fat diet (HFD) was fed to rats for 12 weeks to determine its effects on oxidative stress and inflammation, and compared with HFD + Simvastatin and HFD + EBN (2.5 or 20 %). Weights were measured weekly, while serum and hepatic markers of oxidative stress (total antioxidant status and TBARS) and inflammation (interleukin 6 [IL-6], C-reactive protein [CRP] and tumor necrosis factor alpha [TNF-α]) were determined at the end of the intervention. In addition, transcriptional changes in hepatic antioxidant (superoxide dismutase, glutathione reductase, glutathione peroxidase) and inflammation (C-reactive protein, chemokine [C-C] motif 2, nuclear factor kappa beta 1 and tumor necrosis factor alpha) genes were evaluated.
The results showed increases in oxidative stress (raised TBARS and lowered total antioxidant status) and inflammatory markers (raised CRP, IL-6 and TNF-α) in HFD induced rats with corresponding attenuation of antioxidant gene expression and potentiation of inflammatory gene expression. EBN on the other hand attenuated the HFD-induced inflammation and oxidative stress and produced overall better outcomes in comparison with simvastatin.
In aggregate, the results support the evidence-based utilization of EBN as a supplement for preventing obesity-related inflammation and oxidative stress in rats. These promising results can open up opportunities for translating the benefits of EBN to humans.
The contribution of inflammation to many disease processes is well established. In fact, many chronic diseases have been associated with low grade inflammation . Cardiometabolic diseases have been growing steadily over the years and their burden is expected to rise significantly in the near future if no urgent action is taken. Despite advances in medical healthcare, the currently available strategies for the management of cardiometabolic diseases have not been completely effective in controlling the burden of the diseases. Moreover, side effects are limiting the use of some of these therapies, and hence, the search for newer alternatives. Additionally, links between diet and chronic disease development are now strongly acknowledged, and this new understanding has widened the search for alternative therapies to closely consider dietary methods of managing cardiometabolic diseases .
Edible bird’s nest (EBN) is a traditional supplement consumed for its perceived health-promoting properties, especially among Asians. However, there is lack of scientific research to support the evidence-based use of EBN as a supplement. Recent reports indicate that it possesses antioxidative and anti-inflammatory effects [3–5] but the precise mechanisms underlying such effects are not completely understood. Moreover, these reports are from in vitro systems, which sometimes do not reflect what happens in in vivo systems. Furthermore, the bioactivity of foods with multiple constituents is often attributed to their synergistic effects . This is true of EBN, which has many different constituents including proteins, carbohydrates, fatty acids and other minerals . Additionally, we have recently reported that sialic acid is a major protein constituent of EBN (11 % of EBN), and may in fact be contributing significantly to its bioactivity . However, the contribution of its multiple bioactives towards any of its effects cannot be ruled out in view of the importance of food synergy in foods with multiple constituents like EBN . Thus, in view of the lack of information on the effects of EBN on in vivo oxidative stress and inflammation and the underlying mechanisms involved, we tested the hypothesis that EBN regulated hepatic antioxidant and anti-inflammatory genes in rats as the basis for its antioxidative and anti-inflammatory properties.
C-reactive protein (CRP), interleukin 6 (IL6) and tumor necrosis factor alpha (Tnf-α) ELISA kits were purchased from Elabscience Biotechnology Co., Ltd (Wuhan, China), while 1,1,3,3-tetramethoxypropane (TMP), thiobarbituric acid, potassium persulphate (K2S2O8), 2,2’-azino-bis [3-ethylbenzothiazoline-6-sulphonic acid] (ABTS) reagent, trolox standard and trichloroacetic acid were purchased from Sigma Aldrich (St. Loius, MO, USA). RNA extraction kit was from RBC Bioscience Corp. (Taipei, Taiwan) and GenomeLab™ GeXP Start Kit was from Beckman Coulter Inc (Miami, FL, USA). Simvastatin, RCL2 solution and lipid profile kits were from Pfizer (New York, NY, USA), Alphelys (Toulouse, France) and Randox Laboratories Ltd (Crumlin, County Antrim, UK), respectively. Cholesterol and Cholic acid were purchased from Amresco (Solon, OH, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA), respectively. Standard rat pellet was from Specialty feeds (Glen Forrest, WA, USA), while palm oil was supplied by Yee Lee Edible oils Sdn. Bhd. (Perak, Malaysia). All other solvents were of analytical grade and purchased from Merck (Darmstadt, Germany). EBN supplied by Blossom View Sdn. Bhd (Terrengganu, Malaysia) was cleaned under tap water for 5 mins, dried at room temperature and ground into powder manually using mortar and pestle before incorporating it into rat pellet.
Permission for the use of animals was sought from the Animal Care and Use Committee (ACUC) of the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (Project approval number: UPM/IACUC/AUP-R011/2014), and animals were handled as according to standard guidelines. Sprague dawley rats (10-week old, 230–280 g, n = 30) were maintained under controlled conditions (25 ± 2 °C, 12/12 h light/dark cycle) and after 2 weeks of acclimatization rats were fed HFD containing 4.5 % cholesterol and 0.5 % cholic acid with or without treatment using Simvastatin or EBN (Table 1), except the normal group (n = 6). Intervention lasted for another 12 weeks, after which rats were sacrificed and their organs harvested for further studies. During the intervention, food intake was calculated by subtracting the left-over food from what was added the previous day, and weight was recorded weekly. At the end of the intervention, blood samples and liver tissues were collected for further tests.
Liver Thiobarbituric acid reactive species (TBARS)
Liver tissue TBARS was measured as reported previously with some modifications . Briefly, liver tissue (80 mg) was homogenized in 250 uL of 0.25Hcl and mixed with 250 uL of 0.375 % thiobarbituric acid and 250 uL of 15 % tricholoroacetic acid. Then, the mixture was incubated at 100 °C for 10 min and cooled before centrifuging at 3000 rpm for 15 min. Finally, absorbance of 100 uL of each sample and standard (TMP) were measured on BioTeK Synergy H1 Hybrid Reader (BioTek Instruments Inc., Winooski, VT, USA) at 532 nm, and the results expressed as uM MDA/mg tissue.
Serum total Antioxidant status
ABTS radical scavenging activity was used as a marker of total antioxidant status . Briefly, 6.62 mg of potassium persulphate, K2S2O8 was dissolved in 10 mL of distilled water to prepare a solution of 2.45 mM. Then, 7 mM ABTS was prepared by dissolving 38.4 mg in 10 mL distilled water. The two solutions were mixed and incubated in the dark for 16 h prior to use, and diluted with distilled water until a spectrophotometric absorbance of 0.700 ± 0.005 at 735 nm was obtained. Serum samples (100 μL) were reacted with 900 μL of the diluted ABTS solution and vortexed. The absorbance was read at 734 nm. ABTS radical cation scavenging activity was calculated as the percentage reduction in absorbance.
Serum C-reactive protein, Interleukin-6 and Tumor necrosis factor-alpha
Serum from blood collected in plain tubes was used for measurements of CRP, IL6 and Tnf-α using the respective ELISA kits according to the manufacturers’ instructions. Absorbances were read on BioTeK Synergy H1 Hybrid Reader (BioTek Instruments Inc., Winooski, VT, USA) at the 450 nm. The results were finally expressed as fold change in comparison to normal group:
Fold change = absorbance for the intervention group/absorbance for the normal group
Gene expression study
Primers for the gene expression study (Table 2) were designed using the Rattus norvegicus gene sequences from the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/nucleotide/), and tagged with an 18-nucleotide universal forward and 19-nucleotide universal reverse sequence, respectively. Primers were supplied by Integrated DNA Technologies (Singapore) and reconstituted in RNAse free water. Extracted hepatic RNA (20 ng) was reverse transcribed and used for PCR according to the GenomeLab™ GeXP Start Kit protocol (Beckman Coulter, USA), using the conditions stated on Table 2. PCR products (1 uL) were analyzed on GeXP genomelab genetic analysis system (Beckman Coulter, Inc, Miami, FL, USA) after mixing with sample loading solution and DNA size standard 400 as recommended by the manufacturer. Results were analyzed with the Fragment Analysis module of the GeXP system software and normalized on the eXpress Profiler software.
The means ± standard deviation (n = 6) of the groups were used for the analyses. One-way analysis of variance (ANOVA) was performed using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA) to assess the level of significance of differences between means with a cutoff of p < 0.05.
Results and discussions
EBN attenuated high fat diet-induced oxidative stress
High fat diet-induced weight gain is often accompanied by oxidative stress [11, 12]. In this study, high fat diet increased weight gain and induced oxidative stress, which were attenuated by EBN feeding (Table 1 & Fig. 1). The results indicate that while high fat diet promoted oxidative stress relative to normal group, EBN significantly attenuated such a response, although no significant differences were observed between the EBN groups. Moreover, increased weight has been associated with low grade inflammation and other cardiometabolic health problems . The level of TBARS in the Simvastatin group was also lower than in the untreated control group, but not significantly so. Furthermore, antioxidant status in the different groups indicated that high fat diet reduced antioxidants in comparison with the normal group, while EBN prevented such an effect. Simvastatin was similarly able to prevent reduction in antioxidant status. The ability of EBN to reduce oxidative stress has been ascribed to its antioxidant content, as demonstrated in our recent publication where EBN was shown to possess potent antioxidant abilities that contributed towards lowering of oxidative sterss markers . This is similar to what has been reported on the ability of antixidants to scavenge free radicals thereby lowering oxidative stress . Conversely, the weight and oxidative stress modulatory effects of Simvastatin in rats have been reported previously .
EBN attenuated high fat diet induced inflammation
In the present study, EBN also attenuated EBN-induced inflammatory response after 12 weeks of intervention (Fig. 2). C-reactive protein (CRP), interleukin (IL) 6 and tumor necrosis factor alpha (Tnf-α) were lower in the EBN and Simvastatin groups. These results are in agreement with previous findings on the anti-inflammatory effects of EBN and Simvastatin . Elevated CRP and IL6 have been reported as important markers of the inflammatory response , while Tnf-α is involved in the mediation of a number of processes including the inflammatory process . Moreover, decreases in serum levels of these markers (CRP, IL6 and Tnf-α) has been associated with reduced inflammation [17, 18], and therefore, the present results suggest that EBN has anti-inflammatory effects in in vivo systems. It will be recalled that the anti-inflammatory effects of EBN have thus far been reported using in vitro system , and our report provides more insight into such effects.
EBN regulated hepatic antioxidant and inflammatory genes
Based on the antioxidant and anti-inflammatory effects shown by EBN, we evaluated its effects on hepatic antioxidant and inflammation-related genes (Table 1). High fat diet feeding suppressed the expression of hepatic antioxidant genes (Fig. 3; superoxide dismutase [SOD] 1 and 2, glutathione reductase [Gsr], and glutathione peroxidase [Gpx]), while EBN increased their expression. The results suggest that increased expression of antioxidants through transcriptional regulation may partly underlie the increased antioxidant status in the rats that consumed EBN. Moreover, increased expression of hepatic antioxidant genes has been associated with improved antioxidant status . Also, EBN showed a dose-dependent effect on the expression of antioxidant genes but not serum total antioxidant status possibly because post-transcriptional modifications produced effects to the same degree irrespective of the degree of transcriptional changes induced. The results suggest that EBN will ultimately produce an all-or-none effect notwithstanding the transcriptional changes.
Furthermore, high fat diet feeding increased expression of inflammatory genes (Fig. 4; CRP Tnf-α, chemokine [C-C motif] ligand 2 [CCL2], and nuclear factor Kappa B [nfkb]1), while EBN prevented these high fat diet-induced changes. Increased expression of hepatic inflammatory markers and suppression of the anti-inflammatory marker suggested that high fat diet favoured an increased inflammatory response, in keeping with earlier findings . EBN, on the other hand, prevented the increase in expression of hepatic inflammatory markers, which may underlie the reduced serum inflammatory markers observed in this study; CRP and Tnf-α were reduced in the serum of the EBN groups. However, just as we observed for the hepatic antioxidant genes, the dose-dependent transcriptional changes induced by EBN were not reflected by the results of the serum biomarkers. As can be recalled, these observations may be due to post-transcriptional modifications that produce an all-or-none effect. Interestingly, despite lack of effect of EBN on the expression of the IL6 gene (data not shown), we observed a change in its serum levels. The reduced serum IL6 despite lack of any transcriptional effect of EBN on the IL6 gene EBN further supports our hypothesis that EBN may have multiple targets, and that the transcriptional changes observed in this study may only partly explain the antioxidant and anti-inflammatory effects of EBN. It is clear that other mechanisms are involved in these effects, and are worth studying further.
In aggregate, the ability of EBN to prevent high fat diet-induced weight gain, oxidative stress and inflammation suggests that it may be used as supplement to prevent obesity-associated inflammation and consequent cardiometabolic problems. Already, there are indications that inflammation due to obesity may underlie the cardiovascular and other metabolic diseases that are sequelae of excessive weight gain , and hence EBN may be a good supplement for these problems since it can prevent inflammation, oxidative stress and weight gain. Recently, we demonstrated that the EBN used in this study is predominantly made up of proteins and its effects were likely mediated through synergistic effects of its protein bioactives including sialic acid, lactoferrin and ovotransferrin . Other bioactives may be contributing to this synergistic effect, and these findings are worth evaluating further. The presence of contaminants has also been reported in EBN, which may counter any beneficial effects of EBN. Therefore, future endeavours at studying the health effects of EBN and especially its commercialization must employ stringent screening methods to ensure no toxicity from consumption of EBN.
The data demonstrated that EBN attenuated high fat diet-induced oxidative stress and inflammation partly through transcriptional regulation of hepatic antioxidant and inflammation-related genes, better than Simvastatin. The results also indicated that other post-transcriptional mechanisms may be involved in antioxidant and anti-inflammatory effects of EBN in rats. It is hoped that these findings will open up opportunities for translating the benefits of EBN to humans, and are worth evaluating further.
Edwards T. Inflammation, pain, and chronic disease: an integrative approach to treatment and prevention. Altern Ther Health M. 2005;11(6):20–7.
Parikh P, McDaniel MC, Ashen D, Miller JI, Sorrentino M, Chan V, et al. Diets and Cardiovascular Disease: An Evidence-Based Assessment. J Am Coll Cardiol. 2005;45(9):1379–87.
Vimala B, Hussain H, Nazaimoon WW. Effects of edible bird’s nest on tumour necrosis factor-alpha secretion, nitric oxide production and cell viability of lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Agric Immunol. 2012;23(4):303–14.
Yida Z, Imam MU, Ismail M. In vitro bioaccessibility and antioxidant properties of edible bird’s nest following simulated human gastro-intestinal digestion. BMC Complem Altern M. 2014;14:468.
Yew MY, Koh RY, Chye SM, Othman I, Ng KY. Edible bird’s nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells. BMC Complem Altern M. 2014;14:391.
Jacobs DR, Gross MD, Tapsell LC. Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr. 2009;89(5):1543S–8S.
Marcone MF. Characterization of the edible bird’s nest the “Caviar of the East”. Food Res Int. 2005;38(10):1125–34.
Yida Z, Imam MU, Ismail M, Der Jiun O, Sarega N, Azmi NH, et al. Edible Bird’s Nest Prevents High Fat Diet-Induced Insulin Resistance in Rats. J Diabetes Res. 2015;2015:760535.
Chan KW, Khong NM, Iqbal S, Ch’ng SE, Babji AS. Preparation of clove buds deodorized aqueous extract (CDAE) and evaluation of its potential to improve oxidative stability of chicken meatballs in comparison to synthetic and natural food antioxidants. J Food Qual. 2012;35(3):190–9.
Katalinic V, Modun D, Music I, Boban M. Gender differences in antioxidant capacity of rat tissues determined by 2, 2’-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Phys C. 2005;140(1):47–52.
Milagro FI, Campión J, Martínez JA. Weight Gain Induced by High‐Fat Feeding Involves Increased Liver Oxidative Stress. Obesity. 2006;14(7):1118–23.
Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, et al. Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity. Metabolism. 2008;57(8):1071–7.
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111–7.
Aruoma OI. Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc. 1998;75(2):199–212.
Imam MU, Ishaka A, Ooi DJ, Zamri NDM, Sarega N, Ismail M, et al. Germinated brown rice regulates hepatic cholesterol metabolism and cardiovascular disease risk in hypercholesterolaemic rats. J Funct Foods. 2014;8:193–203.
Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Design. 2012;18(11):1519–30.
Il’yasova D, Ivanova A, Morrow JD, Cesari M, Pahor M. Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers. 2008;13(1):41–51.
Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med. 1993;21(10 Suppl):S447–63.
Ismail M, Al-Naqeep G, Chan KW. Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radical Bio Med. 2010;48(5):664–72.
The authors thank Ministry of Science, Technology and Innovation (MOSTI), Malaysia for sponsoring this research (e-Sciencefund 02-01-04-SF1453) and the staff of the Laboratory of Molecular Biomedicine for their assistance during the study.
The authors declare that they have no competing interests.
Conception of idea and research design: ZY, MI. Conduct of research and experimentation: ZY, MUI, HZ NI, MAA, AI. Data analyses: ZY, MUI. Drafting of manuscript: ZY, MUI. Review and approval of final manuscript: MUI, MI. All authors read and approved the final manuscript.